When was Molcure founded?

Molcure was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is Molcure located?

Molcure is headquartered in Tokyo, Japan.

Who is the current CEO of Molcure?

Ryu Ogawa of Molcure. They have also founded 1 company.

How many employees does Molcure have?

As of May 31, 2026, the latest employee count at Molcure is 22.

Is Molcure a funded company?

Molcure is a funded company, having raised a total of $11.7M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 31, 2013.

When was the latest funding round of Molcure?

Molcure's latest funding was a $***** Series C round on Aug 18, 2021, with participation from 6 investors.

Where does Molcure rank among its competitors?

Molcure ranks 9th amongst 457 active competitors, of which 96 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of Molcure?

Molcure's top competitors include Deep Genomics, Hexagon Bio and BC Platforms. Among them, SeqOne secured the most recent funding round in May, 2025.

Molcure - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of AI-based platform for drug discovery and design. The company uses Next Generation Sequencing and Molecular Biology technology for the discovery and detection of antibody molecules.

Website: molcure.com
Social

Key Metrics

Founded Year

2013

Location

Tokyo, Japan

Stage

Series C

Total Funding

$11.7M in 5 rounds

Latest Funding Round

Series C, Aug 18, 2021, $*****

Investors

JAFCO Group & 8 more

Ranked

9^th among 457 active competitors

Employee Count

22 as on May 31, 2026

Similar Companies

OpenEvidence & 2961 more

View Molcure's full profile

Molcure has raised a total funding of $11.7M over 5 rounds. Its first funding round was on Jul 31, 2013. Its latest funding round was a Series C round on Aug 18, 2021 for $*****. 6 investors participated in its latest round. Molcure has 9 institutional investors.

Here is the list of recent funding rounds of Molcure:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 18, 2021	5921692	Series C	8823720	4630486	9808479	3241048
Dec 03, 2018	2165684	Series B	9382078	7749662	2134436	9945092
2016	1138	Grant (prize money)	7159	9830	6436	Chivas Venture

Access funding benchmarks and valuations. Sign up today!

View details of Molcure's funding rounds and investors

The founders of Molcure are Yoichiro Hara, Ryu Ogawa and Yutaro Kyono. Ryu Ogawa is the CEO of Molcure.

Here are the details of Molcure's key team members:

Yoichiro Hara: Co-Founder & COO of Molcure and founder of 1 other company.
Contact Info: 2 email addresses
Ryu Ogawa: Co-Founder & CEO of Molcure.
Yutaro Kyono: Co-Founder & CTO of Molcure.
Contact Info: 1 email address

View details of Molcure's Founder profiles and Board Members

Molcure's employee count trend

Molcure has 22 employees as of May 26. Here is Molcure's employee count trend over the years:

Uncover Molcure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Molcure include Deep Genomics, Hexagon Bio and BC Platforms. Here is the list of Top 10 competitors of Molcure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	Khosla Ventures, SoftBank Vision Fund & 16 others	63/100
2nd	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
3rd	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Debiopharm, Jolt Capital & 6 others	58/100
4th	Biological Dynamics 2010, San Diego (United States), Series C	Provider of molecular diagnostics plaform	$67.6M	Alexandria, Heritage Group & 6 others	57/100
5th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Supernova Invest, Elaia & 7 others	57/100
6th	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	55/100
7th	Broken String Biosciences 2020, Cambridge (United Kingdom), Series A	Developer of biopharmaceutical products & cell therapies by using genome sequencing data	$15M	Illumina, Illumina Ventures & 14 others	55/100
8th	Zetta Genomics 2018, Worcester (United Kingdom), Seed	Provider of genomic data analysis software for clinical labs & research organizations	$10.4M	Nina Capital, APEX Ventures & 11 others	54/100
9th	Molcure 2013, Tokyo (Japan), Series C	Provider of AI-based platform for drug discovery and design	$11.7M	SBI Investment, Dai-Ichi Life & 7 others	53/100
10th	Phoremost 2015, Cambridge (United Kingdom), Series B	Developer of a phenotypic screening platform for drug target discovery	$76.8M	Parkwalk, Amadeus Capital & 13 others	52/100